Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine
Condition: Rotavirus Vaccine Interventions: Biological: RV3-BB; Biological: Trivalent P2-VP8; Biological: Rotarix; Biological: RV3-BB birth dose; Biological: Trivalent P2-VP8 Booster dose Sponsors: PATH; SK Bioscience Co., Ltd.; Murdoch Childrens Research Institute; Children's Hospital Medical Center, Cincinnati; Bill and Melinda Gates Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials